Influence of erythromycin pre- and co-treatment on single-dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin
- 6 March 1998
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 53 (6) , 469-473
- https://doi.org/10.1007/s002280050408
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: